ArticleChina CDC weekly2025
Development of 3-Year Risk Prediction Model for Type 2 Diabetes in Older Adults with Prediabetes - China, 2019-2022.
Article in China CDC weekly, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
What is already known about this topic?: Prediabetes increases the risk of developing type 2 diabetes. Existing prediction models for incident diabetes from prediabetes have been primarily developed for the general adult population. What is added by this report?: This report introduces a prediction model for progression to diabetes from prediabetes, specifically for older adults, which includes age, exercise, waist circumference, baseline fasting plasma glucose (FPG) and triglyceride concentrations, systolic blood pressure, and dessert intake. What are the implications for public health practice?: The prediction model developed in this study can be used in older adults to identify high risk of progression from prediabetes, defined by FPG, to diabetes, thereby informing targeted interventions and avoiding unnecessary utilization of medical resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.